PTSD Trial, Recruiting NCT05491538 Sponsor: VA Office of Research and Development Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05491538
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are veterans receiving outpatient care and support services at the Minneapolis VA Health Care System.
  • People who are currently working with a mental health team at the Minneapolis VA Health Care System, are motivated to find work, and are looking for employment within 30 miles of the medical center.
  • People who have been formally diagnosed with one of the following conditions: Schizophrenia, Schizoaffective Disorder, Bipolar I Disorder, Bipolar II Disorder, Recurrent Major Depressive Disorder, or PTSD.

Who may not be able to join:

  • People who have a moderate or severe traumatic brain injury.
  • People who have a neurological disease that significantly affects thinking and memory.
  • People whose understanding of English is not sufficient to complete the study's tests and procedures.
  • People whose baseline intellectual ability (measured by a standard assessment) falls below a certain threshold (confirm with trial site).
  • People whose behaviour makes it difficult to take part in a group-based program.
  • People whose hearing or vision difficulties would prevent them from completing the study's activities and assessments.
  • People who are currently experiencing active thoughts of suicide, or who have been hospitalised in the past 4 weeks.
  • People who currently have a severe alcohol or substance use disorder.
  • People who are currently taking part in another mental health intervention research study.
  • People who are unable to commit to 7–9 months of participation due to a planned move or unstable housing situation.
  • People who are unable to provide informed consent to participate.
  • People who have a legally appointed guardian responsible for their personal decisions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tasha Marie Nienow, PhD, Minneapolis VA Health Care System, Minneapolis, MN

Phone: (612) 467-1004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2022
Est. completion
27 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Social Adjustment Scale-Self-Report: Short Version (SAS-SR: Short) Change; Social Adjustment Scale-Self-Report: Short Version (SAS-SR: Short) Change; Recovering Quality of Life (ReQoL)-20 Change; Recovering Quality of Life (ReQoL)-20 Change; Return to Work Self-Efficacy Scale (RTW-SE) Change; Intrinsic Motivation Inventory - Interest subscale; Intrinsic Motivation Inventory - Interest subscale; Intrinsic Motivation Inventory - Value subscale; Intrinsic Motivation Inventory - Value subscale; Client Satisfaction Questionnaire (CSQ-8); Client Satisfaction Questionnaire (CSQ-8); Rate of Treatment...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov